Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity

Adenosine is a neuromodulator in the nervous system and it has recently been observed that pharmacological blockade or gene disruption of adenosine A2A receptors confers neuroprotection under different neurotoxic situations in the brain. We now observed that coapplication of either caffeine (1–25 μM) or the selective A2A receptor antagonist, 4‐(2‐[7‐amino‐2(2‐furyl)(1,2,4)triazolo (2,3‐a)(1,3,5)triazin‐5‐ylamino]ethyl)phenol (ZM 241385, 50 nM), but not the A receptor antagonist, 8‐cyclopentyltheophylline (200 nM), prevented the neuronal cell death caused by exposure of rat cultured cerebellar granule neurons to fragment 25–35 of β‐amyloid protein (25 μM for 48 h), that by itself caused a near three‐fold increase of propidium iodide‐labeled cells. This constitutes the first in vitro evidence to suggest that adenosine A2A receptors may be the molecular target responsible for the observed beneficial effects of caffeine consumption in the development of Alzheimer's disease.

[1]  T. Stone,et al.  Enhanced neuronal damage by co‐administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists , 2002, British journal of pharmacology.

[2]  Alexandre de Mendonça,et al.  Adenosine: does it have a neuroprotective role after all? , 2000, Brain Research Reviews.

[3]  P. Adlard,et al.  The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.

[4]  K. Ikeda,et al.  Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease , 2002, Journal of neurochemistry.

[5]  P. Popoli,et al.  The intrastratial injection of an adenosine A2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease , 1999, Brain Research.

[6]  A. Ascherio,et al.  Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. , 2002, Neurology.

[7]  D. Mogul,et al.  Adenosine A2 receptors modulate hippocampal synaptic transmission via a cyclic-AMP-dependent pathway , 1998, Neuroscience.

[8]  R. Cunha,et al.  ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus , 1997, British journal of pharmacology.

[9]  Y. Chern,et al.  Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells* , 2001, Journal of Biological Chemistry.

[10]  M. Schwarzschild,et al.  Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[11]  D. Souza,et al.  Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons , 2001, Neuroscience Letters.

[12]  R. Cunha,et al.  Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors , 2001, Neurochemistry International.

[13]  R. Cunha,et al.  Adenosine A2A receptors facilitate 45Ca2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes , 1997, Neuroscience Letters.

[14]  R. Boehm,et al.  Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons , 2000, British journal of pharmacology.

[15]  E. Ongini,et al.  Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats , 1998, Neuroreport.

[16]  M. Schwarzschild,et al.  Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice , 2002, Neuroscience Letters.

[17]  R. Guyton,et al.  Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. , 2001, Journal of molecular and cellular cardiology.

[18]  P. Svenningsson,et al.  Pharmacology of adenosine A2A receptors and therapeutic applications. , 2003, Current topics in medicinal chemistry.

[19]  M. Falchi,et al.  Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum , 2002, The Journal of Neuroscience.

[20]  A. de Mendonça,et al.  Does caffeine intake protect from Alzheimer's disease? , 2002, European journal of neurology.

[21]  R. Cunha,et al.  Modification of A‐i and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat , 1995, Neuroreport.